The DNA binding activity of nuclear factor-κB in patients with severe pneumonia and the intervention effects of Xuebijing injection

Chinese Critical Care Medicine

Volumn 22, Issue 9, 2010, Pages 543-546

  Gong, Bei Lei ^a   Zhang, Yong ^a   Xu, Qi Xia ^a   Chen, Yu Qing ^a  

^a BENGBU MEDICAL COLLEGE   (China)

Author keywords

D dimer; Nuclear factor B; Severe pneumonia; Xuebijing injection

Indexed keywords

C REACTIVE PROTEIN; CHINESE DRUG; D DIMER; FIBRINOGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROCALCITONIN; TUMOR NECROSIS FACTOR ALPHA;

ANTICOAGULATION; APACHE; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; FIBRINOLYSIS; HOSPITAL PATIENT; HUMAN; MONOCYTE; PNEUMONIA; PROTEIN BLOOD LEVEL; PROTEIN DNA BINDING; PROTHROMBIN TIME; THROMBIN TIME;

ADULT; AGED; DNA; DNA-BINDING PROTEINS; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MONOCYTES; NF-KAPPA B; PHYTOTHERAPY; PNEUMONIA;

EID: 77958532654     PISSN: 10030603     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1003-0603.2010.09.010     Document Type: Article

References (13)

1. Kawai T, Akira S. TLR signaling. Cell Death Differ, 2006,13:816-825.
2. Peterson RL, Galley HF, Dhillon JK, et al. Increased nuclear factor kappa B activation in critically ill patients who die. Crit Care Med, 2000,28:1047-1051.
3. Castelli GP, Pognani C, Meisner M, et al. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care, 2004,8:R234-242.
4. Inoue K, Takano H, Koike E, et al. Effects of pulmonary exposure to carbon nanotubes on lung and systemic inflammation with coagulatory disturbance induced by lipopolysaccharide in mice. Exp Biol Med (Maywood), 2008,233:1583-1590.
5. Seam N, Suffredini AF. Mechanisms of sepsis and insights from clinical trials. Drug Discov Today Dis Mech, 2007,4:83-93. (Pubitemid 351966332)